|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Program of the 1st International Workshop on
|
||
| Thursday, September 7, 2000 | ||
|
6:00 PM |
Dinner Reception |
|
|
||
| Friday, September 8, 2000 | ||
|
8:00 am |
Classification of Lymphoplamacytoid Disorders and Proctical Issues in Multicenter Clinical Investigations
|
|
|
8:20 am |
Familial Waldenstrom's Macroglobulinemia
|
|
|
8:30 am |
Staging and Prognosis
|
|
|
9:30 am |
Current Therapies | |
|
Veroniique LeBlonde Donna Webber |
Standard Dose Chemotherapy | |
| Bart Barlogie | High Dose Therapy | |
|
11:00 am |
What Should be "Standard" Therapy for Waldenstrom's Macroglobulinemia? | |
|
12:00 pm |
LUNCH | |
|
1:00 pm |
New Strategies | |
| Al Katib | SCID Mouse Model | |
| Bruce Cheson | New Chemotherapy Agents | |
|
John C. Byrd A.Z.S. Rohatiner |
Monoclonal Anitbody Therapy | |
|
Vincent Rajkumar Meletios Dimopoulos |
Anti-angiogenesis Angents | |
| Steven Treon | Novel Targets | |
|
3:00 pm |
Planning Cooperative Group and International Studies
|
|
|
4:00 pm |
Concluding Remarks | |
|
4:15 pm |
Adjourn | |